Unknown

Dataset Information

0

New target for inhibition of bacterial RNA polymerase: 'switch region'.

ABSTRACT: A new drug target - the 'switch region' - has been identified within bacterial RNA polymerase (RNAP), the enzyme that mediates bacterial RNA synthesis. The new target serves as the binding site for compounds that inhibit bacterial RNA synthesis and kill bacteria. Since the new target is present in most bacterial species, compounds that bind to the new target are active against a broad spectrum of bacterial species. Since the new target is different from targets of other antibacterial agents, compounds that bind to the new target are not cross-resistant with other antibacterial agents. Four antibiotics that function through the new target have been identified: myxopyronin, corallopyronin, ripostatin, and lipiarmycin. This review summarizes the switch region, switch-region inhibitors, and implications for antibacterial drug discovery.

SUBMITTER: Srivastava A 

PROVIDER: S-EPMC3196380 | biostudies-literature | 2011 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A new drug target - the 'switch region' - has been identified within bacterial RNA polymerase (RNAP), the enzyme that mediates bacterial RNA synthesis. The new target serves as the binding site for compounds that inhibit bacterial RNA synthesis and kill bacteria. Since the new target is present in most bacterial species, compounds that bind to the new target are active against a broad spectrum of bacterial species. Since the new target is different from targets of other antibacterial agents, com  ...[more]

Similar Datasets

Unknown The RNA polymerase "switch region" is a target for inhibitors.
| S-EPMC2580802 | biostudies-literature
Unknown Novel hybrid-type antimicrobial agents targeting the switch region of bacterial RNA polymerase.
| S-EPMC4027222 | biostudies-literature
Unknown Bidirectional silencing of RNA polymerase I transcription by a strand switch region in Trypanosoma brucei.
| S-EPMC2731899 | biostudies-literature
Unknown An aromatic residue switch in enhancer-dependent bacterial RNA polymerase controls transcription intermediate complex activity.
| S-EPMC3675486 | biostudies-literature
Unknown Old drug, new target: ellipticines selectively inhibit RNA polymerase I transcription.
| S-EPMC3576063 | biostudies-literature
Unknown Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase.
| S-EPMC549610 | biostudies-literature
Unknown Active bacterial modification of the host environment through RNA polymerase II inhibition.
| S-EPMC7880420 | biostudies-literature
Unknown Novel rapidly diversifiable antimicrobial RNA polymerase switch region inhibitors with confirmed mode of action in Haemophilus influenzae.
| S-EPMC3458661 | biostudies-literature
Unknown Orientia tsutsugamushi Is Highly Susceptible to the RNA Polymerase Switch Region Inhibitor Corallopyronin A In Vitro and In Vivo.
| S-EPMC5913972 | biostudies-literature
Unknown Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention.
| S-EPMC4132742 | biostudies-literature